MEDICINE & HEALTHThe US government awards $176 million to Moderna to develop an mRNA influenza vaccine amid bird flu pandemic fears. Discover the potential impact of this initiative.
Pfizer-BioNTech and Moderna vaccines showed high effectivity in preventing elderly adults aged 65 and above from hospitalizations due to COVID-19, a study from the US Centers for Disease Control and Prevention said.
Moderna announced COVID-19 vaccine trials on children 6 months to 12 years old to study the vaccine jab's safety and effectiveness on pediatric patients.
Experts found a few key differences between Moderna, Pfizer, and other COVID-19 vaccines. Here's a peek at what we know and how Moderna differs from others.
Experts are studying the possibility of giving instant long-term immunity to high-risk COVID-19 patients using AstraZeneca's vaccine. Is AstraZeneca winning?
The FDA 'Fast Track' designation may not be as safe as people may believe, warns a medical expert. The cost the people may be paying for vaccines may be a permanent alternation in their DNA.
There's good news from Moderna's mRNA-1273 coronavirus vaccine candidate. A preliminary report states that all 45 volunteers in its clinical trial developed immunity to the coronavirus with no adverse reactions.